Choon Wee Chee - 18 Sep 2025 Form 3 Insider Report for HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: HSDT
Reported as of: 18 Sep 2025
Net transaction value: $0
SEC form: 3
Accepted by SEC: 25 Sep 2025, 17:00:15 UTC
Next SEC filing: 04 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Joseph Chee

Key filing fact

Choon Wee Chee filed Form 3 for HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT) on 25 Sep 2025.

Key facts

This page summarizes Choon Wee Chee's Form 3 filing for HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT).
0 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 25 Sep 2025, 17:00.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002086036 Primary reporting owner

Chee Choon Wee

Relationship: Director, 10%+ Owner
Address: C/O HELIUS MEDICAL TECHNOLOGIES, INC., 642 NEWTOWN YARDLEY RD #100, NEWTOWN
Signature: /s/ Joseph Chee
Signature date: 25 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HSDT holding

COMMON STOCK

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 6,830,402
Date: 18 Sep 2025
Ownership: By Fusion Summer Limited
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HSDT holding Derivative

STAPLED WARRANT

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Sep 2025
Ownership: By Fusion Summer Limited
Underlying class: Common Stock
Underlying amount: 6,830,402
Exercise price: $10.13
Footnotes: F1, F2

HSDT holding Derivative

RESTRICTED STOCK UNIT AWARD

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Sep 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,109,118
Exercise price
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Summer Wisdom Holdings Limited ("Summer Wisdom") holds all ordinary shares of Fusion Summer Limited ("Fusion Summer"). Fusion Summer holds shares of the Issuer's common stock. The Reporting Person is the Controlling Shareholder of Summer Wisdom. Summer Wisdom may be deemed to be the beneficial owner of all of the common stock held by Fusion Summer. The Reporting Person, as the Controlling Shareholder of Summer Wisdom with sole power to exercise investment discretion, may be deemed to be the beneficial owner of all of the common stock held by Fusion Summer. The Reporting Person is the Issuer's Executive Chairman of its Board of Directors.

Footnote F2

The Stapled Warrant may be exercised only during the period beginning September 18, 2025 (the "Issue Date") of the Warrant, and ending on 5:00 p.m., New York City time, on the date that is thirty-six (36) months after the Issue Date of the Warrant.

Footnote F3

The restricted stock units (RSUs) granted on September 18, 2025, are subject to the conditions set forth in the Helius Medical Technologies, Inc. 2022 Equity Incentive Plan.

Footnote F4

Each restricted stock unit represents a contingent right to receive one share of Helius Medical Technologies, Inc. Common Stock.